Literature DB >> 18025237

Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I(2) and E(2) production in human coronary artery endothelial cells.

Xiaoyu Tan1, Suzanne Essengue, Jaya Talreja, Jeff Reese, Daniel J Stechschulte, Kottarappat N Dileepan.   

Abstract

Although histamine plays an essential role in inflammation, its influence on cyclooxygenases (COX) and prostanoid homeostasis is not well understood. In this study, we investigated the effects of histamine on the expression of COX-1 and COX-2 and determined their contribution to the production of PGE(2), prostacyclin (PGI(2)), and thromboxane A(2) in human coronary artery endothelial cells (HCAEC). Incubation of HCAEC monolayers with histamine resulted in marked increases in the expression of COX-2 and production of PGI(2) and PGE(2) with no significant change in the expression of COX-1. Histamine-induced increases in PGI(2) and PGE(2) production were due to increased expression and function of COX-2 because gene silencing by small interfering RNA or inhibition of the catalytic activity by a COX-2 inhibitor blocked prostanoid production. The effects of histamine on COX-2 expression and prostanoid production were mediated through H(1) receptors. In addition to the direct effect, histamine was found to amplify LPS-stimulated COX-2 expression and PGE(2) and PGI(2) production. In contrast, histamine did not stimulate thromboxane A(2) production in resting or LPS-activated HCAEC. Histamine-induced increases in the production of PGE(2) and PGI(2) were associated with increased expression of mRNA encoding PGE(2) and PGI(2) synthases. The physiological role of histamine on the regulation of COX-2 expression in the vasculature is indicated by the findings that the expression of COX-2 mRNA, but not COX-1 mRNA, was markedly reduced in the aortic tissues of histidine decarboxylase null mice. Thus, histamine plays an important role in the regulation of COX-2 expression and prostanoid homeostasis in vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025237      PMCID: PMC2597490          DOI: 10.4049/jimmunol.179.11.7899

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  MyD88 as a bottle neck in Toll/IL-1 signaling.

Authors:  O Takeuchi; S Akira
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 2.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer.

Authors:  Fabio Cianchi; Camillo Cortesini; Nicola Schiavone; Federico Perna; Lucia Magnelli; Elena Fanti; Daniele Bani; Luca Messerini; Valentina Fabbroni; Giuliano Perigli; Sergio Capaccioli; Emanuela Masini
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

4.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 5.  Coupling between cyclooxygenases and terminal prostanoid synthases.

Authors:  Noriko Ueno; Yui Takegoshi; Daisuke Kamei; Ichiro Kudo; Makoto Murakami
Journal:  Biochem Biophys Res Commun       Date:  2005-08-29       Impact factor: 3.575

Review 6.  Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.

Authors:  Jean-Michel Dogné; Julien Hanson; Domenico Pratico
Journal:  Trends Pharmacol Sci       Date:  2005-10-21       Impact factor: 14.819

7.  COX-2-derived prostacyclin confers atheroprotection on female mice.

Authors:  Karine M Egan; John A Lawson; Susanne Fries; Beverley Koller; Daniel J Rader; Emer M Smyth; Garret A Fitzgerald
Journal:  Science       Date:  2004-11-18       Impact factor: 47.728

8.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha.

Authors:  M Kaartinen; A Penttilä; P T Kovanen
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

9.  Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity.

Authors:  M Camacho; J López-Belmonte; L Vila
Journal:  Circ Res       Date:  1998-08-24       Impact factor: 17.367

10.  Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors.

Authors:  I J Elenkov; E Webster; D A Papanicolaou; T A Fleisher; G P Chrousos; R L Wilder
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

View more
  20 in total

1.  A solute carrier family 22 member 3 variant rs3088442 G→A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response.

Authors:  Lu Li; Meian He; Li Zhou; Xiaoping Miao; Fangqing Wu; Suli Huang; Xiayun Dai; Tian Wang; Tangchun Wu
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

2.  Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production.

Authors:  Monika Riederer; Pauli J Ojala; Andelko Hrzenjak; Wolfgang F Graier; Roland Malli; Michaela Tritscher; Martin Hermansson; Bernhard Watzer; Horst Schweer; Gernot Desoye; Akos Heinemann; Sasa Frank
Journal:  J Lipid Res       Date:  2010-07-07       Impact factor: 5.922

3.  Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.

Authors:  Donald D Smith; Xiaoyu Tan; Vineesh V Raveendran; Ossama Tawfik; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-13       Impact factor: 4.733

4.  Anti-histaminic Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts.

Authors:  Amir Farzanegan; Mohammad Shokuhian; Soudeh Jafari; Fatemeh Sadeghi Shirazi; Minoo Shahidi
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

5.  Augmented oxidative stress and preserved vasoconstriction induced by hydrogen peroxide in coronary arteries in obesity: role of COX-2.

Authors:  Elvira Santiago; Maria Pilar Martínez; Belén Climent; Mercedes Muñoz; Ana María Briones; Mercedes Salaices; Albino García-Sacristán; Luis Rivera; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2016-10-07       Impact factor: 8.739

6.  Regulation of the expression of cyclooxygenases and production of prostaglandin I₂ and E₂ in human coronary artery endothelial cells by curcumin.

Authors:  X Tan; E M Poulose; V V Raveendran; B-T Zhu; D J Stechschulte; K N Dileepan
Journal:  J Physiol Pharmacol       Date:  2011-02       Impact factor: 3.011

7.  Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells.

Authors:  Vineesh V Raveendran; Xiaoyu Tan; Matthew E Sweeney; Beth Levant; Joyce Slusser; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Immunology       Date:  2011-01-24       Impact factor: 7.397

8.  Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism.

Authors:  Robert B Cotton; Lisa P Shah; Stanley D Poole; Noah J Ehinger; Naoko Brown; Elaine L Shelton; James C Slaughter; H Scott Baldwin; Bibhash C Paria; Jeff Reese
Journal:  J Mol Cell Cardiol       Date:  2013-02-27       Impact factor: 5.000

9.  Histamine induces Egr-1 expression in human aortic endothelial cells via the H1 receptor-mediated protein kinase Cdelta-dependent ERK activation pathway.

Authors:  Feng Hao; Mingqi Tan; Xuemin Xu; Mei-Zhen Cui
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

10.  Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells.

Authors:  Tongzheng Liu; Ryan A Schneider; Vaibhav Shah; Yongcheng Huang; Rostislav I Likhotvorik; Lakhu Keshvara; Dale G Hoyt
Journal:  J Inflamm (Lond)       Date:  2009-06-22       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.